Follow
Sergio Giralt
Sergio Giralt
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
ML Davila, I Riviere, X Wang, S Bartido, J Park, K Curran, SS Chung, ...
Science translational medicine 6 (224), 224ra25-224ra25, 2014
28032014
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma …
J BladÉ, D Samson, D Reece, J Apperley, B BJÖrkstrand, G Gahrton, ...
British journal of haematology 102 (5), 1115-1123, 1998
19921998
Defining the intensity of conditioning regimens: working definitions
A Bacigalupo, K Ballen, D Rizzo, S Giralt, H Lazarus, V Ho, J Apperley, ...
Biology of blood and marrow transplantation 15 (12), 1628-1633, 2009
17862009
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
RH Collins Jr, O Shpilberg, WR Drobyski, DL Porter, S Giralt, R Champlin, ...
Journal of clinical oncology 15 (2), 433-444, 1997
15491997
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy
S Giralt, E Estey, M Albitar, K Van Besien, G Rondón, P Anderlini, ...
Blood, The Journal of the American Society of Hematology 89 (12), 4531-4536, 1997
14841997
Lenalidomide after stem-cell transplantation for multiple myeloma
PL McCarthy, K Owzar, CC Hofmeister, DD Hurd, H Hassoun, ...
New England Journal of Medicine 366 (19), 1770-1781, 2012
13172012
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for …
IF Khouri, M Keating, M Körbling, D Przepiorka, P Anderlini, S O'Brien, ...
Journal of Clinical Oncology 16 (8), 2817-2824, 1998
11541998
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
10022012
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Y Taur, RR Jenq, MA Perales, ER Littmann, S Morjaria, L Ling, D No, ...
Blood, The Journal of the American Society of Hematology 124 (7), 1174-1182, 2014
8422014
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research
S Giralt, K Ballen, D Rizzo, A Bacigalupo, M Horowitz, M Pasquini, ...
Biology of Blood and Marrow Transplantation 15 (3), 367-369, 2009
8102009
Intestinal Blautia is associated with reduced death from graft-versus-host disease
RR Jenq, Y Taur, SM Devlin, DM Ponce, JD Goldberg, KF Ahr, ...
Biology of Blood and Marrow Transplantation 21 (8), 1373-1383, 2015
7312015
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell …
S Giralt, PF Thall, I Khouri, X Wang, I Braunschweig, C Ippolitti, D Claxton, ...
Blood, The Journal of the American Society of Hematology 97 (3), 631-637, 2001
7032001
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]
M Korbling, D Przepiorka, YO Huh, H Engel, K Van Besien, S Giralt, ...
6791995
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ...
Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002
6592002
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome
JA Coppell, PG Richardson, R Soiffer, PL Martin, NA Kernan, A Chen, ...
Biology of blood and marrow transplantation 16 (2), 157-168, 2010
6502010
Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes
BL Scott, MC Pasquini, BR Logan, J Wu, SM Devine, DL Porter, ...
Journal of Clinical Oncology 35 (11), 1154, 2017
5882017
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with …
BL McClune, DJ Weisdorf, TL Pedersen, GT Da Silva, MS Tallman, ...
Journal of Clinical Oncology 28 (11), 1878, 2010
5372010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ...
Journal of clinical oncology 28 (33), 4976-4984, 2010
5292010
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
M Dimopoulos, R Kyle, JP Fermand, SV Rajkumar, J San Miguel, ...
Blood, The Journal of the American Society of Hematology 117 (18), 4701-4705, 2011
5272011
Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ...
New England Journal of Medicine 382 (9), 822-834, 2020
4972020
The system can't perform the operation now. Try again later.
Articles 1–20